首页> 外文期刊>Health affairs >Medicare Prescription Drug Plan Enrollees Report Less Positive Experiences Than Their Medicare Advantage Counterparts
【24h】

Medicare Prescription Drug Plan Enrollees Report Less Positive Experiences Than Their Medicare Advantage Counterparts

机译:Medicare处方药计划参与者所报告的积极经验少于其Medicare Advantage对手

获取原文
获取原文并翻译 | 示例
           

摘要

Since 2006, Medicare beneficiaries have been able to obtain prescription drug coverage through standalone prescription drug plans or their Medicare Advantage (MA) health plan, options exercised in 2015 by 72 percent of beneficiaries. Using data from community-dwelling Medicare beneficiaries older than age sixty-four in 700 plans surveyed from 2007 to 2014, we compared beneficiaries' assessments of Medicare prescription drug coverage when provided by standalone plans or integrated into an MA plan. Beneficiaries in standalone plans consistently reported less positive experiences with prescription drug plans (ease of getting medications, getting coverage information, and getting cost information) than their MA counterparts. Because MA plans are responsible for overall health care costs, they might have more integrated systems and greater incentives than standalone prescription drug plans to provide enrollees medications and information effectively, including, since 2010, quality bonus payments to these MA plans under provisions of the Affordable Care Act.
机译:自2006年以来,Medicare受益人已经能够通过独立的处方药计划或其Medicare Advantage(MA)健康计划获得处方药承保,2015年,有72%的受益人行使了选择权。使用2007年至2014年调查的700份计划中来自64岁以上社区居民的Medicare受益人的数据,我们比较了独立计划提供或纳入MA计划时受益人对Medicare处方药承保范围的评估。与MA同行相比,独立计划中的受益人始终报告处方药计划的积极经验(易于获得药物,获得承保范围信息和获得成本信息)更少。由于MA计划负责总体医疗保健费用,因此与独立的处方药计划相比,它们可能具有更多的集成系统和更大的激励机制,从而可以有效地向已登记的患者提供药物和信息,包括自2010年以来,根据Affordable条款向这些MA计划提供质量奖金护理法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号